Back to Results

Perceptive Capital Solutions Corp (FRNM)

Perceptive Capital Solutions Corp is a NASDAQ-listed common stock company classified within Financials and Capital Markets. The company does not currently have significant operating activities. Instead, it was formed to pursue a business combination such as a merger, share exchange, asset acquisition, share purchase, or reorganization with one or more businesses. Its stated focus is on opportunities in the life sciences and medical technology sectors, with potential targets in North America or Europe. Incorporated in 2024, the company is based in New York, New York.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-FRNM
$9.24
-27.6% Downside
Overvalued
$18
41.0% Upside
Undervalued
Fair
0.0%
November 10, 2026
38.7x
1.372 B
2.945 B
10.3%
46.3%
-5.3
52.7%
Valuation • Fair Value

Perceptive Capital Solutions Corp (NASDAQ-FRNM) Fair Value by Valuation Model

Review the available estimates for Perceptive Capital Solutions Corp (NASDAQ-FRNM), including Comps Fair Value.

Primary Valuation Read

Fair Value

$9.24

Estimated downside of 27.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Comps Fair Value

$9.24

Comparable-company valuation reference.

Analyst Price Target

$18

Analysts imply upside of 41.0%.

How to read these valuation models

Use the 4 available valuation references for Perceptive Capital Solutions Corp (NASDAQ-FRNM) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Perceptive Capital Solutions Corp (NASDAQ-FRNM)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

35.41 M

Current operating scale indicator.

Revenue Forecast

130.3 M

Forward revenue estimate.

EBITDA

-206 M

Current operating profitability reference.

EBITDA Forecast

900 K

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Perceptive Capital Solutions Corp (NASDAQ-FRNM) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Perceptive Capital Solutions Corp (NASDAQ-FRNM)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

Altman Z-Score

-5.3

Lower score that deserves closer risk review.

FCF / Net Income

52.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Perceptive Capital Solutions Corp (NASDAQ-FRNM). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Perceptive Capital Solutions Corp (NASDAQ-FRNM)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

17

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Perceptive Capital Solutions Corp (NASDAQ-FRNM), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Perceptive Capital Solutions Corp (NASDAQ-FRNM) Stock Forecast & Technical Outlook

Review Perceptive Capital Solutions Corp (NASDAQ-FRNM) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Perceptive Capital Solutions Corp (NASDAQ-FRNM)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Perceptive Capital Solutions Corp (NASDAQ-FRNM) has a Strong Buy consensus, with 5 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 0
Sell 0
FAQ • Fast Investor Answers

Perceptive Capital Solutions Corp (NASDAQ-FRNM) Stock FAQ

Data-supported answers about Perceptive Capital Solutions Corp (NASDAQ-FRNM), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$9.24
Estimated downside 27.6%
Valuation Rating
Overvalued
Estimated downside of 27.6%
Analyst Target
$18
Implied upside 41.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is $9.24. This implies an estimated downside of 27.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 27.6% versus the current market price.

The available analyst price target for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is $18. The analyst target implies estimated upside of 41.0%.

The current financial health read for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Perceptive Capital Solutions Corp (NASDAQ-FRNM) is November 10, 2026.

The latest available data indicates no current dividend yield for Perceptive Capital Solutions Corp (NASDAQ-FRNM).

The current market capitalization listed for Perceptive Capital Solutions Corp is 1.372 B.

The current enterprise value listed for Perceptive Capital Solutions Corp is 2.945 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Perceptive Capital Solutions Corp is NASDAQ-FRNM, and the stock is listed on NASDAQ.

Perceptive Capital Solutions Corp (NASDAQ-FRNM) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Perceptive Capital Solutions Corp is 10.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Perceptive Capital Solutions Corp is 46.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

TMO NYSE Thermo Fisher Scientific Inc Fair Value Fair Market Cap 249.1 B
DHR NYSE Danaher Corporation Fair Value Fair Market Cap 162.2 B
A NYSE Agilent Technologies Inc Fair Value Fair Market Cap 48.793 B
IQV NYSE IQVIA Holdings Inc Fair Value Fair Market Cap 45.983 B
WAT NYSE Waters Corporation Fair Value Overvalued Market Cap 44.572 B
ILMN NASDAQ Illumina Inc Fair Value Overvalued Market Cap 40.682 B
MTD NYSE Mettler-Toledo International Inc Fair Value Fair Market Cap 33.467 B
WST NYSE West Pharmaceutical Services Inc Fair Value Fair Market Cap 27.598 B
MEDP NASDAQ Medpace Holdings Inc Fair Value Fair Market Cap 18.715 B
RVTY NYSE Revvity Inc Fair Value Overvalued Market Cap 17.717 B
CRL NYSE Charles River Laboratories Fair Value Overvalued Market Cap 16.488 B
ICLR NASDAQ ICON PLC Fair Value Fair Market Cap 14.294 B
TEM NASDAQ Tempus AI Inc Fair Value Overvalued Market Cap 12.2 B
AVTR NYSE Avantor Inc Fair Value Fair Market Cap 11.694 B
TECH NASDAQ Bio-Techne Corp Fair Value Fair Market Cap 11.377 B
QGEN NYSE Qiagen NV Fair Value Fair Market Cap 10.421 B
RGEN NASDAQ Repligen Corporation Fair Value Overvalued Market Cap 9.985 B
BIOB NYSE Bio-Rad Laboratories B Fair Value Fair Market Cap 9.862 B
BIO NYSE Bio-Rad Laboratories Inc Fair Value Fair Market Cap 9.862 B
TXG NASDAQ 10X Genomics Inc Fair Value Overvalued Market Cap 9.322 B